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ABSTRACT: We combine state-of-the-art computational crystal struc-
ture prediction (CSP) techniques with a wide range of experimental
crystallization methods to understand and explore crystal structure in
pharmaceuticals and minimize the risk of unanticipated late-appearing
polymorphs. Initially, we demonstrate the power of CSP to rationalize the
difficulty in obtaining polymorphs of the well-known pharmaceutical
isoniazid and show that CSP provides the structure of the recently
obtained, but unsolved, Form III of this drug despite there being only a
single resolved form for almost 70 years. More dramatically, our blind
CSP study predicts a significant risk of polymorphism for the related
iproniazid. Employing a wide variety of experimental techniques, including high-pressure experiments, we experimentally obtained
the first three known nonsolvated crystal forms of iproniazid, all of which were successfully predicted in the CSP procedure. We
demonstrate the power of CSP methods and free energy calculations to rationalize the observed elusiveness of the third form of
iproniazid, the success of high-pressure experiments in obtaining it, and the ability of our synergistic computational-experimental
approach to “de-risk” solid form landscapes.
■ INTRODUCTION
Significance of Late-Appearing Polymorphism. Poly-
morphism is the existence of multiple crystal structures with
identical chemical compositions for a particular chemical
compound.1−3 Many pharmaceutical drugs display poly-
morphism and the different structures have different
physicochemical properties such as solubility, hydration
stability, etc., which can markedly impact the overall drug
efficacy.4 In addition, factors such as crystal morphology and
particle size can influence the drug’s formulation and
processing properties.5 Thus, a thorough understanding of
the solid form landscape of a particular compound provides the
opportunity to fine-tune material properties.
Polymorph screening, using a wide range of experimental
parameters and procedures, has become routine across the
solid-state sciences. Famously, McCrone stated that “the
number of forms known for a given compound is proportional
to the time and energy spent in research on that compound.”6
Indeed, there are many compounds for which an extraordinary
number of forms have been discovered. For instance, the tenth
form of galunisertib,7 the twelfth form of aripiprazole,8 and the
fourteenth polymorph of ROY9,10 have all been reported. Such
a high degree of polymorphism is uncommon, however, and
some compounds are monomorphic, i.e., they have only one
known pure crystal structure, e.g., Pigment Yellow 74,11
fenamic acid,12 and the bromo derivative of ROY.13 In the
ideal case, this is achieved through close packing to give a
dense crystal with all potential directional intermolecular
interactions being optimal, with no alternatives of comparable
stability.14
However, it can be premature to assume that a compound is
monomorphic based on empirical evidence alone, as there exist
a number of examples of late-appearing polymorphs of
compounds previously considered to have only a single form,
sometimes with significant consequences. Until very recently,
isoniazid (ISN) had only one resolved solid form, and the
difficulty in obtaining any other crystal structures, despite the
molecule being known for almost 70 years, led to it being
characterized as monomorphic.15 Recently, two new forms
were discovered viacrystallization from the melt,16 finally
revealing its polymorphism and confirming hints of additional
forms suggested by thermomicroscopy experiments decades
prior.17
The most famous case of late-appearing polymorphism is
that of ritonavir, an antiretroviral drug synthesized by Abbott
Laboratories with a late-appearing polymorph that resulted in a
two-year halt in production and $250 million in lost sales.1,18,19
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Bucǎr et al. have discussed 10 other cases of elusive or
disappearing polymorphs.1 For example, the dopamine agonist
rotigotine, first produced in 1985, was only known to exist in
one crystal structure.20 However, almost 30 years after its
discovery, the appearance of a new crystalline form in the
Neupro patches stopped its clinical use. The patches were
eventually reformulated as a stable amorphous matrix, but
during this process, patches were unavailable for four years.
Clearly, it is extremely desirable to avoid these late-appearing
forms and to be confident that all likely polymorphs of a
compound have been discovered and, ideally, fully charac-
terized.
The late appearance of thermodynamic forms may be due to
unfavorable crystallization kinetics, but once an energetically
preferred form crystallizes, it can inhibit the formation of
previously known metastable forms.21 Interestingly, both
ritonavir and rotigotine are examples of conformational
polymorphism, in which different molecular conformations
are adopted in the polymorphs and the need for conforma-
tional change may contribute to the nucleation barrier for a
particular form.
The discovery of novel forms is aided by increasingly
sophisticated crystallization techniques, e.g., the templating of
the catemeric Form V of carbamazepine via sublimation onto
the isostructural dihydrocarbamazepine,22 the crystallization of
novel β-coronene under an external magnetic field,23 and the
crystallization of two novel forms of adefovir dipivoxil in ionic
liquids.24 These kinds of experiments are unlikely to feature in
a traditional polymorph screen, and hence, combined
experimental and computational modeling approaches using
a broad range of techniques are needed to minimize the risk of
a late-occurring, stable solid form.
It is in this context that computational methods for crystal
structure prediction (CSP) can be employed to understand
these risks.25−28 At a basic level, predicting, enumerating, and
ranking the stable crystalline forms of a given molecule can
provide a picture of what crystal forms are possible and
whether the most highly ranked structures (by a chosen
scoring function, typically the lattice energy) have all already
been experimentally characterized. The results of CSP can,
therefore, motivate additional effort in exploring crystallization
conditions.29 At a more sophisticated level, there is the
possibility of guiding the experimental polymorph search, both
by predicting new forms’ existence and by suggesting
conditions under which they might be produced, either to
streamline efforts to obtain them or to highlight conditions
that should be avoided to minimize the risk of their formation.
Computational approaches can also offer insight into the
likelihood of the formation of novel polymorphs under
nonambient conditions, particularly high pressure, as was
performed post hoc for 2-fluorophenol and 4-chlorophenol,30
and more recently used a priori to predict high-pressure
polymorphs of the pharmaceutical dalcetrapib.21 However,
experimental crystallization of high-pressure polymorphs is
often not thermodynamically controlled,31 frustrating direct
comparison between computed high-pressure thermodynamics
and high-pressure crystallization experiments. Calculation of
crystal structure free energy rather than static lattice
energy32−35 can close the gap between the simulation
environment and experimental conditions, but these require
expensive and sensitive dynamical calculations.
It is well-known that the “energy landscapes” provided by
CSP, the set of predicted stable crystal structures, ranked by
their static lattice energy, feature many more unique structures
than have been observed even for highly polymorphic
molecules like ROY.36 Clearly, not every structure predicted
by a CSP procedure is a feasible polymorph, so to be useful,
CSP must suggest which structures are in the “danger zone” on
the landscape, i.e., those that are likely to crystallize alongside
or instead of the known or desired form(s).
Rationalizing Polymorph Risk through Computed
Energetics. To define this “danger zone”, previous work has
demonstrated that computed lattice energy differences
between experimentally observed polymorphs for a wide
range of organic molecules are usually smaller than 2 kJ/mol,
less than 7.2 kJ/mol in 95% of cases, and extending beyond 10
kJ/mol in only rare cases.32 These statistics can be applied to
assess the likelihood of observing predicted polymorphs of a
target molecule based on their lattice energy difference relative
to the lowest-energy structure. From an experimental
perspective, this energy window could be measured relative
to the lowest energy observed structure. However, this makes
the interpretation of CSP results dependent on the extent of
experimental screening and thus system-dependent and subject
to change if a lower energy structure is observed. With the
results of CSP in hand, assuming that the computational
exploration for structures is complete and that the energetic
ranking is accurate, we know the structure and the energy of
the lowest energy possible crystal structure. This global energy
minimum should always be assumed to be an observable
crystal structure, even if the kinetics of crystallization to this
structure are unfavorable. Thus, where CSP has been
performed, the most consistent choice of reference for the
energetic window of polymorphism is the predicted global
minimum, ensuring that the analysis is applied consistently
where CSP has been performed “blind”, in advance of any
known structures, and to systems with crystal structures
already known.
While the main focus of polymorph risk analysis is normally
the identification of polymorphs that are thermodynamically
more stable than structures that are already known,7,37 higher
energy polymorphs are of interest for a complete under-
standing of a molecule’s solid form diversity. Desolvation of
solvates has been demonstrated as a route to high energy
polymorphs, but their instability and difficulties in obtaining
high quality crystals of these forms may make them
underrepresented in studies of the energy range of poly-
morphism, which rely on fully determined crystal structures.
The relative energies of such desolvated structures can vary
widely. Forms II and III of galunisertib, for example, are 8−10
kJ/mol higher in energy than the (unobserved) CSP global
minimum and only accessible via desolvation.7 In other cases,
desolvated structures’ relative energies can range from +15 kJ/
mol38 to +25 kJ/mol,39 and even up to +50 kJ/mol in the case
of porous organic frameworks.40 Clearly, if desolvation or other
high energy processes for obtaining alternative forms are under
consideration then the energy window considered relevant in
CSP must widen significantly.
Regardless, to make any confident prediction of mono-
morphism (or completely characterized polymorphism), the
sampling of possible structures must be sufficiently extensive to
have found all the relevant (low-energy) candidates and the
method for obtaining their relative energies must be
sufficiently accurate.25 The sampling problem is one of the
biggest challenges of CSP due to the high dimensionality of the
search space and is made even more difficult when molecular
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flexibility adds to the number of degrees of freedom. A routine,
rudimentary approach for treating flexibility is to sample the
crystal packing possibilities of multiple molecular conformers
generated from isolated-molecule optimizations. This approach
assumes that the in-crystal conformation is nearly equivalent to
a stable gas-phase conformer but allows for less stable
conformers that might lead to more favorable packing
interactions to be considered in the CSP procedure. The
advantage of this CSP approach is that the cost of the
procedure increases only linearly with the number of
conformers considered; the disadvantage is that it does not
allow for significant conformational distortions of a gas-phase
minimum that might be stabilized (or kinetically trapped) by
subsequently favorable packing arrangements.
The severity of this rigid-molecule approximation can be
relieved by optimizing the final crystal structures using a
method that allows intramolecular degrees of freedom to relax.
The most commonly employed such method is periodic
density functional theory (DFT).25 Refinement of predicted
structures with DFT also often provides improved energetic
rankings and computed properties of the structures compared
to the force fields used in the initial structure generation and
minimization, albeit at a considerably increased computational
cost.
In this work, we combine CSP with both traditional and
nontraditional experimental crystallization approaches to
explore the polymorphism of two related molecules, ISN and
iproniazid (IPN), Figure 1. As described, until very recently,16
only one nonsolvated crystal structure of ISN was reported
despite screening; our previous, more targeted attempts at gel-
assisted crystallizations (with two mimetic gelators) as well as
microemulsion crystallization experiments did not obtain any
new forms.15 Even so, there were hints of other possible forms
(from the aforementioned thermal microscopy experiments)
that had not been further described in almost 50 years.17 The
recent work of Zhang et al.16 has located two metastable forms
(Forms II and III) of ISN via crystallization from the melt. Of
these, only Form II’s structure could be fully solved, and a unit
cell was proposed for Form III from powder X-ray diffraction
data. The elusiveness of these forms of ISN in previous
experiments, combined with the tractability of ISN from a CSP
perspective as a small, conformationally rigid molecule, make it
an ideal candidate for further experimental screening combined
with computational study.
The structural analogue IPN was the first monoamine
oxidase inhibitor and the isopropyl group adds to its
conformational flexibility. This may give rise to conformational
polymorphism in the solid state in a manner that is unavailable
to ISN, as well as possible differences in observed hydrogen
bonding motifs due to having one fewer terminal hydrazine
hydrogen compared to ISN. Thus, we were interested in how
this chemical change impacts the crystal structure landscape.
Furthermore, IPN has no reported crystal structures beyond a
phosphate salt41 and is therefore an excellent candidate with
which to undertake a fresh cooperative experimental and
computational polymorph screen more akin to the screening
process in the pharmaceutical industry.
We aim to predict and characterize the polymorph
landscapes for these compounds as completely as possible.
We begin by predicting “blindly” (i.e., with no prior crystal
structure information) the CSP landscape of ISN and IPN.
Armed with this knowledge, we attempt to crystallize as many
as possible of the forms that appear from the CSP landscapes
to be experimentally “at risk” of formation. We determine this
risk based in part on the 7.2 kJ/mol energy window for likely
polymorphism but with particular emphasis on locating the
global energy minimum predicted structure. Our experimental
screen incorporates a wide range of techniques, typical solvent
screening methods, templated sublimations, gel-phase crystal-
lizations, and high-pressure experiments, to maximize our
ability to locate any elusive, metastable, or previously
unobserved polymorphs. Finally, we combine the information
from both approaches to characterize the observed forms and
assess the risk of late-appearing polymorphism for both
compounds.
■ COMPUTATIONAL METHODS AND CSP
PROCEDURE
Generation of Hypothetical Structures via CSP. Initial
molecular conformers for both molecules were generated via a
combined molecular mechanics sampling and DFT optimization
procedure (described more fully in the Supporting Information). This
procedure yielded a single conformer for ISN, and for IPN a set of five
conformers labeled A through E in order of decreasing relative
stability (see the Supporting Information for diagrams). All five
conformers lay within 5 kJ/mol of the global gas-phase minimum, i.e.,
with conformational energies well within the expected energy bounds
for observed crystal structures.42
For each conformer of each molecule, hypothetical crystal packing
arrangements were generated with rigid molecular geometries, in our
global lattice energy explorer method,43 details of which are described
fully in previous work. The search was restricted to the 25 most
common space groups (see the Supporting Information) observed in
the Cambridge Structural Database44 for one molecule in the
asymmetric unit (Z′ = 1) and, for isoniazid, also Z′ = 2. Such
restrictions on the complexity of the asymmetric unit are a crucial
assumption in CSP for maintaining tractable computational cost;
however, it precludes the identification of higher Z′ structures and
those in unusual space groups. The recently discovered ISN Form II
has unusually low symmetry, with four independent molecules in the
asymmetric unit (Z′ = 4) and represents a considerable challenge for
any CSP effort, due to the number of independent degrees of
freedom. Given that there was limited evidence of any polymorphs of
ISN at the outset of our work, a search up to Z′ = 2 represents a
reasonable compromise between exploration and affordability.
The hypothetical packing arrangements were optimized in a
multistage process of successively higher-accuracy energy minimiza-
tion methods, progressing from rigid-molecule pairwise force field
models using the DMACRYS software45 (see the Supporting
Information for a complete description) to a periodic DFT
optimization and ranking of the most stable structures. Duplicate
structures were removed by automated comparison of computed
PXRD patterns obtained via the PLATON46 program. For the final
optimization in periodic DFT, we used the PBE functional47 and
Grimme’s D3 dispersion correction48 with Becke-Johnson damping
(GD3BJ)49 and a plane-wave basis set, using the VASP50−53 software
package. All atomic degrees of freedom and unit cell parameters were
relaxed in the final stage of the procedure, which introduces a
description of the molecular flexibility in response to the crystal
packing arrangement.
Figure 1. Molecular structures of isoniazid (ISN) and iproniazid
(IPN).
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Predicting Free Energies. The energy landscapes obtained via
the above methods are computed under the assumption of a static
crystal structure; no thermal effects or zero-point energy are included.
This is a significant approximation but necessary to manage
computational cost. Once a sufficiently small number of plausible
structures have been identified, it becomes tractable to predict free
energy differences. For ordered crystal structures, the most important
contribution to free energies beyond the static energy arises from the
dynamics of the crystal structure: the zero-point vibrational energy
and the phonon modes populated at finite temperature, which
contribute the vibrational term Fvib(T) to the Helmholtz free energy
A(T):
= +A T E F T( ) ( )latt vib
Fvib(T) is calculated from the phonon frequencies derived from DFT
(PBE-GD3BJ). We employed the Phonopy54 package to obtain the
phonon frequencies via finite displacements, calculating energies in
VASP for a supercell of each structure; the supercell dimensions are
chosen to correspond to sampling reciprocal space q-points of at most
0.12 Å−1 spacing, which has been demonstrated32,33 to be sufficiently
converged for polymorph vibrational energy differences. Phonopy
employs a variant of the Parlinski-Li-Kawazoe method55 for
interpolating between explicitly sampled q-points. It is critical to
ensure that structures are at true minima to obtain reliable frequencies
of vibration about the atomic equilibrium positions; hence, structures
were reoptimized with significantly more stringent convergence
criteria (1000 eV basis set cutoff, 0.005 eV/Å in forces) before the
dynamical matrix was calculated.
Free energy calculations were improved by employing the Debye
model to describe the acoustic mode contribution to the phonon
density of states from the Brillouin zone center to the nearest sampled
q-point.33 We obtain the elastic tensor from the DFT calculations and
calculate an orientationally averaged velocity of sound in the crystal,
from which a Debye frequency was determined and used to calculate a
correction term for long-wavelength acoustic contributions to Fvib(T).
Details are provided in our previous work.33
■ EXPERIMENTAL METHODS
Experimental methods were undertaken continuously in unison with
the computational studies.
Solution Crystallizations and Gel Phase Crystallizations.
Solution crystallizations were performed by the heating of a saturated
solution of either ISN or IPN until completely dissolved. The
solutions were left to cool slowly in a heating block. These were
carried out in parallel with gel-phase crystallizations under the same
conditions but in which the heated solution was used to dissolve the
gelator (1 w/v%). Then the solutions were also left to cool slowly in
the heating blocks.
Templated Sublimations. The powder of the sample being
sublimed was placed on a glass slide and then on a Linkam LTS420
heating stage. The templating crystal was affixed to a borosilicate glass
coverslip with a small amount of Vaseline and then separated from the
glass slide with a small rubber O-ring. The powders were then heated
to a temperature to achieve sublimation, 131 °C for IPN and 141 °C
for ISN at either 5 or 10 °C/min for 6 h to ensure that all the sample
sublimes and then the sample was left at the set temperature overnight
to allow for crystal growth.
High-Pressure Experiments. High-pressure experiments were
conducted by compressing crystals that were grown at ambient
pressure in a Merrill−Bassett diamond anvil cell (DAC)56 using
Fluorinert FC-70 as an inert pressure transmitting fluid. A 250 μm
thick stainless steel gasket was preindented to ca. 150 μm and drilled
with a 300 μm precision hole to create the sample chamber between
the two diamond anvils, culet size of 800 μm. The pressure inside the
cell was measured after equilibration using a ruby sphere included in
the sample chamber by the R1 ruby fluorescence method.
57 The
diamond anvil cell was directly attached to a goniometer head and
mounted on the diffractometer. Data were collected using the
XIPHOS II diffractometer at Newcastle University, using a four-circle
Huber Eulerian goniometer with offset chi cradle fitted with a Bruker
APEX II CCD area detector and an Ag Kα IμS generator. Data
collections of crystals in DACs are poor at locating H atom positions
due to shading by the gasket and DAC, which reduces the
completeness of the data set.58−60
Novel crystal structures of iproniazid are reported; Forms I and II
were produced by slow cooling, and Form III was produced by high-
pressure experiments. A more detailed analysis of these novel forms,
as well as details on gelator synthesis, characterization methods, and
computational processes (molecular conformer generation, space
group selection for structure generation and structure minimization)
and further results of the free energy calculations are all available in
the Supporting Information.
■ RESULTS AND DISCUSSION
Isoniazid Crystal Structure Prediction. The CSP results
for isoniazid are shown in Figure 2. The pronounced global
minimum energy structure accurately reproduces the histor-
ically observed, thermodynamically most stable structure Form
I, known since 1954. All of the other structures generated by
CSP lie at least 6.5 kJ/mol higher, at the upper reaches of the
expected energy window for polymorphism. The global
minimum of the Z′ = 2 search is also isostructural to Form
I, but in a lower-symmetry space group; relaxing the symmetry
constraints has not yielded any lower-energy structures other
than Form I. Duplicate structures occurring within the Z′ sets
have been removed, but duplicates between sets (e.g., Form I,
the global minima in each) have been retained to emphasize
that removing the symmetry constraints still locates many of
the same low-energy structures as in the Z′ = 1 search,
providing reassurance of sufficiently thorough sampling.
Figure 2. CSP landscape for isoniazid (ISN), in which the lowest-
energy predicted structure (circled in solid black) matches the
longest-known experimentally observed form. Orange crosses indicate
structures generated assuming only one isoniazid molecule in the
asymmetric unit (Z′ = 1), while blue triangles indicate Z′ = 2. The
global energy minimum structure was located in searches with Z′ = 1
and Z′ = 2 (the two points at −134 kJ/mol, 1.48 g/cm3). The pink
circle shows where the recently discovered Z′ = 4 Form II lies when
optimized using the same methods, while the broken circle indicates
the CSP structure whose lattice parameters and computed PXRD
pattern closely match those of the unsolved Form III. Energies and
densities are obtained from PBE+GD3BJ periodic DFT.
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Such a clear thermodynamic preference for an experimen-
tally observed structure in a CSP landscape is unusual,61,62
molecules typically exhibit multiple low-lying structures on the
CSP landscape well inside the energy window of risk (even if
these structures have not been observed), and in cases where a
crystal structure is known a priori, it is not necessarily the
global lattice energy minimum (which may indicate a risk of
the spontaneous formation of this more stable polymorph).
The existence of Form I as the global minimum in lattice
energy and the size of the energy gap between it and other
structures (at this level of theory and within the space groups
and Z′ values considered) helps to rationalize the previously
long-held empirical conclusion that this molecule had only one
accessible crystal structure. If ISN were a novel compound
undergoing screening, we would suggest on this basis that the
risk of late-appearing, stable polymorphs would be low,
particularly if high-energy processes such as desolvation of
solvatomorphs are not being considered.
The recent work of Zhang et al.16 in obtaining two new
isoniazid polymorphs (Forms II and III) occurred contempo-
raneously with the present study and refutes these previous
conclusions of monomorphism. Form III is a highly metastable
polymorph that converts rapidly to Form I and proved too
short-lived for full characterization. The unit cell proposed for
Form III (3.931(2) Å, 9.754(5) Å, 8.568(4) Å) from
synchrotron powder diffraction is in excellent agreement with
those of the second-lowest energy predicted structure (a =
3.751 Å, b = 17.164 Å, c = 9.692 Å, β= 95.67, P21/c, Z′ = 1),
i.e., the most plausible polymorphic candidate from CSP
(Figure 2, broken circle, 6.5 kJ/mol above the global
minimum), apart from cell doubling in one direction (b
from our CSP structure is double c from PXRD indexing).16
The computed PXRD pattern for our CSP structure is also in
good agreement with the experimental pattern (Figure 3);
reflections present in the experimental pattern but absent from
our prediction (noted by red arrows in Figure 3) correspond to
Form I reflections, due to conversion during sample
preparation (see the Supporting Information of ref 16).
Hence, we propose that our predicted structure corresponds
to the experimental Form III.
Form II, with Z′ = 4, would be unlikely to be found in a
typical blind CSP attempt. Lattice energy minimization of the
structure reported by Zhang et al. places Form II 5.5 kJ/mol
above the global minimum (Figure 2, pink circle), within the
expected energy range for polymorphism. The high calculated
energies of Forms II and III, relative to Form I, agree with the
experimentally observed metastability of these polymorphs,
which transform rapidly to Form I, and the energetic ordering
agrees with the room temperature stability ranking (I > II >
III) from the experiment.16
Iproniazid Crystal Structure Prediction. The CSP
results for IPN, with Z′ = 1 structures generated from 5
distinct molecular conformers, are shown in Figure 4. As is
common in blind CSP, we posit that the global minimum
energy structure (in space group P21/c), which is also the
global density maximum, is the most likely to be observed
experimentally.26 A close-lying predicted structure (space
group P21) is approximately 1 kJ/mol higher in energy, and
we propose as a likely polymorph. These are followed by a gap,
then a more varied, nearly continuous distribution of possible
structures starting approximately 5 kJ/mol above the global
minimum.
All but 2 of the 13 structures within the characteristic
polymorphic energy window of 7.2 kJ/mol feature either the
gas-phase minimum conformer A or the fourth-lowest energy
conformer D, indicating that the latter can compensate for its
higher conformational energy with improved intermolecular
interactions or denser packing. Indeed, the global minimum
energy (and maximum density) crystal structure features
conformer D. Unlike in the case of ISN, there is an alternative
structure (featuring conformer A) within a very small energy
gap of the global minimum. While not every static lattice
energy minimum on a CSP landscape is guaranteed to be an
observable polymorph,36 we consider the presence of two
predicted structures based on different molecular conformers
at the bottom of the energy landscape as an indication of
multiple likely, stable polymorphs of IPN.
Figure 3. Comparison of experimental PXRD pattern (black,
originally presented by Zheng et al.) for Form III of ISN and the
computed PXRD pattern (blue) for the second-lowest energy CSP
structure. Intensities of each pattern have been scaled to the value of
the largest peak in each case. The red arrows highlight peaks in the
experimental pattern that we do not predict but which correspond to
reflections in the PXRD pattern of Form I of ISN.
Figure 4. CSP landscape for iproniazid (IPN). Data point color
denotes space group number, while the shapes of points indicate the
gas-phase conformer used to generate the initial crystal structure, with
A being the gas-phase global minimum conformation. In subsequent
crystallization experiments, Forms I and II of IPN matched the
structures in the solid and dashed black circles, respectively. The
global static lattice energy minimum, in the dotted circle, would
eventually be located via high-pressure experiments as Form III.
Energies and densities are obtained from PBE+GD3BJ periodic DFT.
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Comparison of Predicted Hydrogen Bond Motifs.
Isoniazid. The global minimum structure of ISN from the CSP
landscape, which matches the experimental structure Form I,
features hydrogen bonding between the pyridyl group of one
ISN molecule and the terminal amine group of another,
forming a C1
1(8) chain (Figure 5a). These chains are in turn
linked to each other with N−H···N bonds between the
terminal amine and the hydrazide nitrogen atom in an adjacent
molecule. However, the carbonyl group does not participate in
any H-bonding in Form I.
The CSP structure matching Form III, in contrast, features
the same terminal amine N−H···N(pyridyl) chains instead
linked by (hydrazide)N−H···O(carbonyl) bonds (Figure 5c).
While this and several of the predicted higher-energy structures
feature H-bonding motifs that involve the carbonyl group as an
acceptor (always in a carbonyl-hydrazide H-bond, sometimes
sharing the oxygen atom with a carbonyl-amine H-bond), it
appears that involving the carbonyl is unnecessary to form a
particularly stable crystal structure of ISN, in opposition to
what might be expected based on Etter’s rules.63
Form II of ISN displays noticeably different hydrogen
bonding to Form I or Form III in a more complex arrangement
because of its low symmetry (Z′ = 4). Only 2 of the 4
symmetry-inequivalent molecules exhibit pyridyl-acceptor H-
bonding, both via a neighboring hydrazide N−H donor rather
than pyridyl-amine chains. However, in all 4 molecules the H-
bonding involves all the available protons (terminal amine and
hydrazide) and the carbonyl oxygen (Figure 5b).
Iproniazid. In contrast with ISN, many of the low-energy
predicted structures (e.g., 12 of 13 structures within the 7.2 kJ/
mol window) display hydrogen bonding involving the carbonyl
group (most commonly to the hydrazide N−H), suggesting
that the carbonyl acting as an acceptor is energetically optimal.
The variety of H-bonding patterns available in predicted
structures of IPN is reduced compared to ISN by the lack of
the accessible terminal amine group, e.g., the pyridyl group
appears less likely to participate in H-bonding due to the
isopropyl group precluding the formation of end-to-end
molecular chains. Instead the second N−H typically H-
bonds to other infinite H-bonding chains of IPN (Figure 5d).
Experimental Crystallization of ISN and IPN. The
crystallization of ISN was carried out in 26 solvents via slow
cooling of saturated solutions and through the slow
evaporation of ISN solutions. In all cases, the known form of
ISN was produced, as first reported in 1954.64 As a result,
sublimation experiments were also undertaken as they have
previously been used to crystallize metastable forms.65 −67 ISN
was sublimed by heating on a microscope stage below its
melting point (171.4 °C) at relatively high heating rates (5 and
10 °C/min). A borosilicate glass coverslip was placed above
the sample and the ISN vapor crystallized on the colder
coverslip. However, no new forms were obtained.
For iproniazid, slow cooling and slow evaporation in 22
solvents resulted in 14 samples exhibiting diffraction quality
crystals. The crystals are all colorless and plate-like (Figure 6).
Single crystal X-ray diffraction shows that almost all of the
crystals are of the same, new form, designated Form I (IPN-I),
in the monoclinic space group P21.
In one instance, crystallization from slow cooling of a
saturated toluene solution of IPN produced a second form of
IPN, designated Form II (IPN-II), in space group Pbca; as with
IPN-I, the structure has Z′ = 1. Despite multiple attempts, it
was not possible to reproduce this form through solvent
crystallization methods, suggesting that IPN-II is likely to have
a high barrier to nucleation in solution and is metastable with
respect to or is outgrown by IPN-I.68 Indeed, slurry
experiments, in which both forms were added to a saturated
solution, resulted in only IPN-I, as confirmed by PXRD
(Figure S1), demonstrating that IPN-I is the more stable form
under ambient conditions. IPN-II was, however, reproducibly
obtained by the sublimation of IPN powder onto borosilicate
coverslips.
Comparison of the structural information and geometric
overlays using Mercury69 (Figure S2) of both IPN Forms I and
II with the CSP structures reveals excellent matches with two
predicted structures, located 5.8 (Form II) and 1.1 (Form I)
kJ/mol above the global minimum. Therefore, both these
forms of IPN were correctly predicted by CSP, with energies
consistent with the statistics for observed polymorphs. The
metastable IPN-II is located higher in the energy landscape,
Figure 5. Hydrogen bonding for (a) ISN-I, (b) ISN-II, (c) ISN-III,
and (d) the global minimum energy structure of IPN. Blue lines
indicate intermolecular hydrogen bond interactions.
Figure 6. Photos of IPN crystals (a) Form I grown from slow cooling
a saturated nitrobenzene solution and (b) Form II produced via the
sublimation of IPN powder on a borosilicate coverslip. Unit cell (c)
Form I and (d) Form II.
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while IPN-I matches the second-lowest energy predicted
structure; thus, the predicted energetic ordering of these two
forms is consistent with the experimental observation that
IPN-I is more readily obtained and more stable than IPN-II.
However, these solution and sublimation crystallization
experiments did not yield crystals corresponding to the global
energy minimum on the CSP landscape. Furthermore, the
landscape (Figure 4) contains multiple structures that are of
very similar energy to IPN-II. It is not apparent why IPN-II is
experimentally observed while similarly metastable structures
and the global minimum are not obtained. Both observations
indicate that the risk of late-appearing polymorphism of IPN
remains after conventional solvent screening and sublimation.
Gel-Phase Crystallizations. Gel phase crystallization is an
emerging technique for expanding the polymorphism search
space70,71 and was undertaken for ISN and IPN with a series of
gelators (Figure 7). Gelator 1 mimics the structure of ISN and
IPN and parallels the use of other drug-mimetic gelators that
have previously been shown to stabilize metastable forms over
the thermodynamically favored polymorph,70 as well as
resulting in the discovery of new solvates.72 Gelators 2 and 3
were chosen to mimic coformers known to form cocrystals
with ISN. The cocrystals of ISN are polymorphic and exhibit
different H-bonding motifs with the carbonyl and pyridyl
groups both being H-bond acceptors.73−75 Thus, these gelators
may be able to template forms with different H-bonding
motifs. Gelator 4 forms gels in aromatic solvents and therefore
was chosen in an attempt to recover Form II in toluene.
These experiments were carried out at the same solute
concentration as the slow cooling crystallizations. For each
experiment, either ISN or IPN and then the gelator were
dissolved with heating and sonication and left to cool under
ambient conditions. In all cases, Form I of both ISN and IPN
were obtained, demonstrating the strong preference for these
forms to crystallize over any other predicted structures.
Templated Sublimations. Previous work has demon-
strated that it is possible to template the growth of a particular
form and discover new polymorphs by subliming onto different
surfaces, e.g., polycrystalline powders,76 siloxane-coated glass,65
and crystals with related structure.32,33 Both Forms I and II of
IPN display different hydrogen bonding patterns to the known
form of ISN and hence crystals of one compound could be
used to template the growth of new forms of the other
analogue.
In the CSP landscapes, the lowest energy IPN structure with
ISN-like H-bonding is 7.0 kJ/mol above the global minimum.
Conversely, on the ISN landscape, the lowest energy structure
displaying IPN-like H-bonding (i.e., involving the carbonyl
group) is the CSP structure that we propose matches Form III
of ISN, 6.5 kJ/mol higher in energy than Form I. While these
energy differences are toward the higher end of the energy
range of expected polymorphism based on experimental
statistics, they remain plausible risks. This assessment is
borne out in the case of ISN with the recent experimental
production of Form III, but it is also significant for IPN, as the
observable Form II is only 1.2 kJ/mol more stable than the
aforementioned lowest-energy ISN-like structure.
Sublimation of each compound was attempted using crystals
of either ISN or IPN as a template for the other by
crystallization directly from the vapor phase. Crystals of both
compounds did grow on top of the surface of the parent
template (Figure S3), but in both cases the same polymorph
was produced (Form I ISN or Form II IPN) as sublimation
crystallization in the absence of the template. These experi-
ments further qualify the risk of further metastable forms of
ISN/IPN with unusual H-bonding patterns; these calculated
forms, along with the global minimum form of IPN, appear to
be inaccessible through these methods.
We also attempted to seed melt crystallizations with using
either ISN or IPN as a template for the other. However, we did
not observe changes to crystal morphology (using polarized
optical microscopy) or changes of melting temperatures during
the reheating measurements and concluded that seeding was
unsuccessful. Hence, we did not pursue such experiments
further.
Elusive High-Density Form of Iproniazid. The calcu-
lated global energy minimum form of IPN is notably denser
than either of the forms experimentally obtained. While it is
not unprecedented that the first-discovered or most exper-
imentally accessible structure is not the global energy
minimum on a CSP landscape, the lower energy and
significantly greater density together single this prediction
out for further efforts. From the perspective of confidence in
solid form screening, an unobserved CSP global minimum
represents a major risk and a priority for experimental work. A
higher-density polymorph should become comparatively even
more stable under higher pressure, suggesting high pressure
crystallization as a means to obtain this form experimentally.
Geometry optimizations under pressure show that the
energy difference between IPN-I and the global minimum
CSP structure widens from −0.7 at zero applied pressure to
−7.6 kJ/mol at P = 2.4 GPa (Figure 8). This is expected, as the
global minimum is already the densest predicted structure and
therefore no “crossover” in ranking is expected with increased
pressure. While this trend agrees with physical intuition, it
provides no clarity as to why this global minimum structure is
not found in conventional crystallization experiments.
Evidently, static lattice energy calculations alone are not
enough to rationalize the elusiveness of the high-density form.
Computed Free Energies of Iproniazid. Given the
increased possibility of obtaining the elusive high-density
predicted structure of IPN under elevated pressures, a more
Figure 7. Chemical structures of gelators used in this study.
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useful quantity to compute is the free energy change as a
function of both temperature and pressure. However, the latter
is a computationally expensive proposition, as each step in
pressure requires new phonons to be calculated as the crystal
structure is compressed. To provide some estimate of the free
energy difference between the forms under higher pressure, we
make the approximation that the pressure and vibrational
effects are independent and purely additive, i.e., we compute
vibrational contributions to the free energy only for the
ambient pressure structures and add these to the PV
contribution. These approximate free energies are shown in
Figure 8.
With dynamical effects incorporated into the calculations,
the static CSP global minimum becomes metastable with
respect to IPN-I at ambient pressure, being 2.8 kJ/mol higher
in free energy at 300 K. In fact, the missing high-density form
of IPN is computed to be higher in free energy at ambient
pressure than IPN-I across all temperatures; the vibrational
zero-point energy (ZPE) difference of 1.8 kJ/mol between the
two forms reranks them even before any thermal contributions.
It is known that vibrational ZPE can be important in relative
polymorph ranking, particularly for some hydrogen-bonded
species.77,78 In these cases, an accurate treatment of lattice
dynamics is necessary to obtain an estimate of the ZPE and
hence polymorph rankings that are consistent with exper-
imental observations, as appears to be the case for IPN.
Having considered both temperature and pressure, the
elusiveness of the high-density form is more easily explained:
this structure is metastable at standard temperature and
pressure with respect to IPN-I, with a considerably larger
energy difference between structures than the static calcu-
lations alone indicated. As expected, increased pressure
stabilizes this high-density form, with higher temperatures
requiring higher applied pressures to make it more favorable
than IPN-I. While our approximation of additivity of the
vibrational and PV terms compounds the uncertainty in the
free energy, the results indicate that at 300 K an applied
pressure in excess of 1.0 GPa would be required to make the
high-density structure most favorable.
Given this reordering, we should consider whether other
predicted structures could similarly become competitive with
IPN-I in free energy terms with increasing temperature or
pressure. The expense and sensitivity of calculating the
periodic DFT phonon frequencies makes it desirable to
estimate in which cases reordering is likely without carrying
out the full calculation on many structures. Our previous work
has demonstrated that the vibrational contribution to
polymorphic free energy differences rarely exceeds 2 kJ/mol
at room temperature.32 Given that the third lowest energy
predicted structure of IPN is 3.8 kJ/mol higher in static lattice
energy than IPN-I, any of the higher energy structures are
considered unlikely to become more stable in free energy at
room temperature, and so we restrict our full free energy
treatment to IPN-I and the high-density global minimum
structure. (The expected range in magnitude of this entropic
contribution also justifies our decision to consider only static
lattice energies for ISN, as no predicted structures are likely to
become competitive with Form I at room temperature.)
Assessing the polymorphic risk of the IPN landscape based
on calculated free energies, the global lattice energy minimum
is now less of a risk than indicated by the static calculations
alone. This demonstrates the power of computational work to
identify risks in crystallization processes but also highlights the
importance of thorough, rigorous application of advanced
methods to provide accurate insight. If assessments of risk are
made on the basis of “black-box” CSP approaches alone, using
static lattice energies (as in Figure 4), then this maximal
density structure would be perceived as a serious risk as a late
appearing, stable polymorph because it is the global minimum
on such a landscape. This risk is diminished somewhat when
free energy (including quantum vibrational effects) is
considered, as dynamical contributions rerank the two
structures and suggest IPN-I is in fact most stable. However,
the free energy difference between the two remains well within
the “danger zone” of polymorphism at ambient pressure, and
hence, it is prudent to explore whether high-pressure
experiments can indeed obtain this form as the free energy
trends in Figure 8 indicate.
High-Pressure Experiments. The global lattice energy
minimum on the IPN landscape contains the molecule in a
less-stable conformation than that of IPN-I or IPN-II. This
conformation may have a sufficiently high nucleation barrier
that it cannot be crystallized by solution phase, gel phase, or
sublimation screening as its crystallization is kinetically
hindered. Similar observations were made for ritonavir and
rotigotine whereby the thermodynamically favored forms were
conformationally different from the metastable forms and were
not discovered for many years.
As the CSP static global minimum structure is significantly
denser than IPN-I and IPN-II, it is stabilized by higher
pressures, due to the smaller pressure−volume contribution to
the free energy; this is shown by the free energy calculations
(Figure 8). High-pressure experiments are known to be
capable of effecting conformational change in crystal
structures.79,80 Thus, both high-pressure recrystallization and
compression of crystals grown at ambient pressures were
undertaken in Merrill−Bassett diamond anvil cells (DACs).
All attempts to recrystallize IPN from solution at various
pressures produced polycrystalline samples. This may be due
to the many surfaces on which nucleation can occur inside the
DAC, e.g., the ruby spheres, the edge of the tungsten gasket, or
Figure 8. Computed energy difference, ΔE, between IPN-I and the
global minimum in lattice energy (reference value) as a function of
pressure. Gray ■ are static lattice energies including the PV
contribution; the remaining data are Helmholtz free energies
presented at three different temperatures: 0 K (black ○), i.e., only
ZPE contributions, 100 K (blue +), and 300 K (red ×). Values were
calculated via periodic PBE+GD3BJ; vibrational contributions were
corrected with a Debye model for low-frequency modes.
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the faces of the diamond.81 As a result, we turned to
compression of crystals grown at ambient pressure.
At lower pressures (≤0.3 GPa), only slight reductions in the
unit cell dimensions were observed for IPN-II (Table S1).
However, the compression is anisotropic, affecting mostly the b
axis. At higher pressures (ca. 0.5−0.8 GPa), the crystal breaks
perpendicular to the longest axis, indicating that this form is
unable to compress further or transform to relieve the stress
caused by the elevated pressure.
When IPN-I was compressed up to ca. 2.1 GPa, no changes
to the crystal habit could be observed visually. However, single
crystal X-ray diffraction confirmed that under hydrostatic
pressure, IPN-I (P21) undergoes a single crystal-to-single
crystal transformation to produce a new structure, IPN-III
(P21/c). Pressure-mediated transformations without the
destruction or dissolution of the crystal are rare but can be
achieved for molecules with conformational flexibility.81 Single
crystal-to-single crystal transformations have been achieved for
other organic molecules through conformational changes, e.g.,
β-glycine to δ-glycine,82 glutathione-I to glutathione-II,58 and
di-p-tolyl disulfide α form to β form.83 In the present case, this
transformation results in a conformational change such that the
structure closely matches the predicted conformer D.
Structural overlay (Figure S4) confirms that this new form
corresponds to the predicted global lattice energy minimum
structure of IPN.
Upon decompression to ambient pressure, the crystallinity
of the sample was significantly reduced because of damage to
the crystal from compression, decompression, and X-ray
irradiation. However, it proved possible to obtain an ambient
pressure structure determination, which while of low precision
and data completeness unambiguously identifies that Form III
is retained after decompression and removal from the DAC.
Comparison of the crystallographic data for the Form III high-
pressure data and the data for the crystal recovered from the
DAC are available in the ESI (Table S2). This key result
indicates that Form III represents a considerable risk as a late-
appearing polymorph, if created in an industrial setting under
milling conditions, for example.
Crystal Packing Analysis. Differences in the packing of
the polymorphs of IPN explain why Form I rather than Form
II transforms to Form III and why Form III is the densest
polymorph. The three IPN polymorphs exhibit a similar H-
bonding motif, a C1
1(4) chain with the carbonyl group as an
acceptor and the donor being the N−H adjacent to the
carbonyl of the next molecule (Figure 9 and Figure 10). These
are the shortest contacts for all forms, and they appear as two
spikes on the 2D fingerprint plots of the IPN Hirshfeld surfaces
(Figures S5 and S6), which were used to visualize the
differences in intermolecular interactions. For IPN-I, the H-
bonding chains run parallel to the b-axis and only a small
compression of the b-axis is observed upon transition to IPN-
III (Table 1). This is commensurate with only a small
reduction in the H-bond length in IPN-III (Table S2).
Similarly, these chains run parallel to the a-axis for IPN-II and
only a modest reduction of this axis is recorded after
compression in the DAC (Table S1). This is in line with
previous studies that the shortest contacts remain unchanged
and transformations instead rely on a rearrangement of longer
contacts.84,85
Accordingly, there are some subtle differences between
forms in the interactions of the pyridyl groups in adjacent H-
bonding chains. All IPN forms exhibit a short contact between
the pyridyl groups via a (pyridyl)C−H···N(pyridyl) inter-
action. For IPN-I and IPN-II, these are C1
1(3) chains, which
stack in a herringbone-like manner. These contacts in IPN-II
are longer than in IPN-I (Table S3), indicating poorer packing.
The compression of IPN-I significantly reduces the a-axis (the
c-axis in IPN-III), such that the pyridyl groups are less offset
from one another. The conformational change also results in
the two pyridyl rings becoming nearly coplanar. These changes
transform these contacts to R2
2(6) rings in IPN-III which are
noticeably shorter than in the other forms (Figure S8g, Table
S3); further, the H-bonding chains now run antiparallel to one
another (Figure 9).
Together, the H-bonding chains and the pyridyl−pyridyl
contacts produce sheets that connect the IPN molecules
(Figure 10) in all three forms. These sheets are additionally
held together by (hydrazine)N−H···N(hydrazine) H-bond
interactions (Figure S9a and S10). The shorter pyridyl−pyridyl
contacts in IPN-III allow the sheets to stack closer together,
while the antiparallel chains and the conformational change
allows rotation of the isopropyl group for denser packing
Figure 9. Hydrogen bonding for (a) IPN-I, (b) IPN-II and (c) IPN-
III. Blue lines indicate interactions between molecules.
Figure 10. H-bonding sheets of IPN visualized perpendicular to the
H-bonding chains with alternative sheets colored red and blue. Blue
lines represent interactions between IPN molecules. (a) IPN-I, (b)
IPN-III, and (c) IPN-II.
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within these sheets (Figure S9d); both effects contribute to
IPN-III being the densest. Further analysis of the packing and
presentation of the Hirshfeld fingerprint plots can be found in
the Supporting Information.
In IPN-II, the b-axis is normal to the plane of these sheets
(Figure S10), and it is this axis along which IPN-II compresses
before breaking under pressure. It is speculated that these
sheets compress together rather than the H-bonding chains to
accommodate the pressure increases.
Though all three forms contain these H-bonded sheets, the
shape of the sheets in IPN-I and IPN-III is notably different
from those in IPN-II. The sheets of both Forms I and III are
relatively planar, with gentle undulations. In contrast, those of
Form II are more corrugated, having an increased roughness
(rugosity) with neighboring sheets interpenetrating more
(Figure 10). As these sheets in IPN-II are very different to
those in IPN-III, there is no obvious route for transformation
to IPN-III, in contrast to IPN-I which only needs to undergo a
comparatively small change in the sheet structure. Topological
rugosity has been linked to slip planes for crystals which affect
the mechanical properties and thus the tablet ability of
different forms.86,87 Therefore, it is expected that the different
forms of IPN may behave differently during formulation,
particularly if tabletting pressures cause the transformation
from IPN-I to IPN-III that can persist at ambient pressure.
Given the structural differences, however, we do not expect
IPN-II to transform due to pressure during the tableting
process.
■ CONCLUSIONS
We have demonstrated the power of computational CSP
methods to rationalize the difficulty in obtaining polymorphs
of isoniazid, due to the absence of any competitive predicted
thermodynamic minima (assuming Z′ ≤ 2). Solvent and
sublimation-based crystallization methods did not reveal any
further forms beyond the long-known Form I, consistent with
previous screening.15
The contemporaneous discovery by Zhang et al. of two new
forms from melt crystallization16 is remarkable but consistent
with our computational findings in both cases. Form II would
not be predicted in a typical CSP due to its high Z′, making a
search prohibitively expensive in the general case. However,
the structure of Form II is ranked favorably in energy when
treated with our computational methods, and within the range
of likely energy differences between observed polymorphs.
Similarly, the second-lowest energy CSP structure of ISN lies
somewhat higher in energy but still within the usual range for
polymorphism and matches the PXRD pattern of Form III,
which could not be fully characterized experimentally.
Therefore, although our initial assumptions precluded our
CSP procedure from predicting Form II, Form III was
predicted as the most likely polymorphic structure, albeit
with an energy that suggests it would be challenging to isolate
(and arguably agreeing with its experimental instability). Thus,
our approach successfully predicted the only other Z′ = 1
structure of ISN yet discovered and has revealed its crystal
structure.
More significantly, a blind CSP of the analogue iproniazid
predicted a polymorphic system with at least two notably low-
energy structures and several metastable ones. An exhaustive
experimental screening process, including solvent-based, gel-
phase, and sublimation crystallization, successfully obtained
two of the predicted structures: the stable Form I and
metastable Form II. However, the global minimum on the
static energy landscape, the densest predicted structure,
remained elusive despite its predicted thermodynamic stability.
It was only through diamond anvil compression experiments
that this structure, Form III, was obtained experimentally.
Detailed free-energy calculations representing the state-of-the-
art in CSP techniques rationalize the stability relationship
between Forms I and III. Form III is not the global energetic
minimum when thermal effects are considered but is
obtainable when experimental searching is guided by CSP.
Once formed by compression, Form III persists at ambient
pressure and hence CSP has revealed a high-risk late appearing
polymorph and indicated the conditions under which it is
formed.
This work demonstrates the power of combining exhaustive
experimental screening with modern CSP methods to elucidate
the risk of late-appearing polymorphism. We emphasize the
synergy between the two fields; CSP of iproniazid suggested a
significant risk of polymorphism, which justified a thorough
experimental screening that obtained Forms I and II. When the
most likely structure according to CSP eluded this screening,
further computational analysis via free energy calculations
rationalized its elusiveness, while high-pressure experiments
motivated by the predicted maximal density of this structure
successfully yielded Form III. The crystallization and character-
ization of three polymorphs of iproniazid, for which no pure
crystal structure was previously available, is tangible evidence
of the value of this combined approach for exploring and “de-
risking” solid form landscapes.
Table 1. Crystallographic Data for the Three Polymorphs of
IPN
crystal form Form I Form II Form III
formula C9H13N3O C9H13N3O C9H13N3O
molecular weight/g
mol−1
179.219 179.219 179.219
crystal system monoclinic orthorhombic monoclinic
space group P21 Pbca P21/c
T/K 120 120 291
pressure/GPa ambient ambient 2.21
a/Å 8.1440(8) 4.9971(7) 11.240(5)
b/Å 5.0966(5) 16.831(3) 5.043(3)
c/Å 11.7207(13) 22.850(3) 15.171(14)
α/° 90 90 90
β/° 107.122(4) 90 109.14(7)
γ/° 90 90 90
V/Å3 464.93(8) 1921.7(5) 812.4(10)
Z 2 8 4
Z′ 1 1 1
ρcalc/g cm
−3 1.280 1.239 1.465
independent
reflections
3067 [Rint =
0.0731]
1577 [Rint =
0.0918]
287 [Rint =
0.0851]
goodness-of-fit 1.024 1.060 1.082
final R indexes [I ≥
2σ(I)]
R1 = 0.0501 R1 = 0.0398 R1 = 0.0987
wR2 = 0.1033 wR2 = 0.0857 wR2 = 0.2524
final R indexes [all
data]
R1 = 0.0719 R1 = 0.0612 R1 = 0.1434
wR2 = 0.1111 wR2 = 0.0945 wR2 = 0.2863
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